Skip to main content
Premium Trial:

Request an Annual Quote

Larry Felser, John Tyson, Mike Shuler, John Guckenheimer, Christoph Lengauer, Keith Dunker


Larry Felser has been named director of systems and software development for Gene Network Sciences, of Ithaca, NY. Felser, who will oversee the company’s cell modeling and simulation platform, most recently was a software development director at Autodesk. The company has also appointed four new members to its scientific advisory board. John Tyson, a professor of molecular cell biology at Virginia Tech, and Mike Shuler, a Cornell University professor of chemical engineering, both were selected for their experience in cell system and biochemical circuit modeling. John Guckenheimer, a Cornell mathematics professor, is an expert in dynamical systems and chaos theory, and Christoph Lengauer, an assistant professor of oncology at the Johns Hopkins University School of Medicine, has studied the genetics and cell biology of colon cancer. The 22-person company plans to grow to 34 in the near future.


Keith Dunker has signed on as director of the center for bioinformatics at Ingen, the Indiana Genomics Inititative, and as a professor at IU School of Medicine in Indianapolis. Dunker has been a professor at Washington State University since 1975, and uses bioinformatics to study the relationship between protein folding and function.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.